Connection

SUZANNE FUQUA to Transcription, Genetic

This is a "connection" page, showing publications SUZANNE FUQUA has written about Transcription, Genetic.
Connection Strength

0.712
  1. Sp1 is essential for estrogen receptor alpha gene transcription. J Steroid Biochem Mol Biol. 2002 Sep; 82(1):7-18.
    View in: PubMed
    Score: 0.136
  2. Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity. Nucleic Acids Res. 2020 02 28; 48(4):1800-1810.
    View in: PubMed
    Score: 0.114
  3. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Clin Cancer Res. 1995 Feb; 1(2):155-9.
    View in: PubMed
    Score: 0.080
  4. A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. Biotechniques. 1990 Aug; 9(2):206-11.
    View in: PubMed
    Score: 0.059
  5. Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Res. 2006 Jun 01; 66(11):5950-9.
    View in: PubMed
    Score: 0.044
  6. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol. 2006 Sep; 20(9):2020-35.
    View in: PubMed
    Score: 0.044
  7. Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1 and ERalpha. Breast Cancer Res Treat. 2004 May; 85(2):111-20.
    View in: PubMed
    Score: 0.038
  8. Proteomic profiling identifies key coactivators utilized by mutant ERa proteins as potential new therapeutic targets. Oncogene. 2018 08; 37(33):4581-4598.
    View in: PubMed
    Score: 0.025
  9. Estrogen receptor variants. J Mammary Gland Biol Neoplasia. 1998 Jan; 3(1):73-83.
    View in: PubMed
    Score: 0.025
  10. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res. 1997 Apr 01; 57(7):1244-9.
    View in: PubMed
    Score: 0.023
  11. Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells. Biochem Biophys Res Commun. 1996 May 06; 222(1):155-63.
    View in: PubMed
    Score: 0.022
  12. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res Treat. 1993; 26(2):191-202.
    View in: PubMed
    Score: 0.017
  13. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 1992 Jan 15; 52(2):483-6.
    View in: PubMed
    Score: 0.016
  14. The importance of normal and abnormal oestrogen receptor in breast cancer. Cancer Surv. 1992; 14:31-40.
    View in: PubMed
    Score: 0.016
  15. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991 Jan 01; 51(1):105-9.
    View in: PubMed
    Score: 0.015
  16. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. Mol Endocrinol. 2009 Apr; 23(4):454-65.
    View in: PubMed
    Score: 0.013
  17. P-glycoprotein expression in human breast cancer cells. Cancer Res. 1987 Apr 15; 47(8):2103-6.
    View in: PubMed
    Score: 0.012
  18. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst. 2000 Dec 06; 92(23):1926-34.
    View in: PubMed
    Score: 0.008
  19. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines. Br J Cancer. 1995 May; 71(5):974-80.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.